The Foundation to Advance Vascular Cures' CEO, Isabel Bjork, Appointed to National Research Institute’s Advisory Panel
September 27, 2023 — Isabel Bjork, CEO of the Foundation to Advance Vascular Cures has been appointed by the Patient-Centered Outcomes Research Institute (PCORI) as a member of its Advisory Panel on Clinical Effectiveness and Decision Science.
Bjork will join other members of the panel in applying her experience and expertise to helping PCORI refine and prioritize the research it funds. She will also ensure that the research PCORI supports centers on the outcomes that matter to patients and other healthcare decision-makers.
PCORI is an independent, nonprofit organization authorized by Congress to fund research that will provide patients, their caregivers and clinicians with the evidence-based information needed to make better-informed healthcare decisions. Panel members represent a broad range of healthcare stakeholder groups and perspectives, including patients, family caregivers, clinicians, drug and device makers and researchers, among others.
Isabel brings extensive experience in strategic leadership, having provided executive oversight to the Genomics Institute and the Foundation to Advance Vascular Cures. Her adeptness in building translational research programs, such as the nationally-recognized Treehouse Childhood Cancer Initiative, coupled with her proficiency in strategic partnerships and commitment to patient and caregiver engagement in research positions her as an asset to the PCORI Advisory Panel.
